In recent years, there were significantly increasing research studies focused on the anti-tumor properties of PDE5 inhibitors both in academic and clinic, especially when drug repurposing has become a very effective strategy for both cancer prevention and therapy. This evidence concerns the gene PDE5A and cancer.